Volume 68, Issue 3 | Page 13

for the premature infant. With a blood volume of 90 mL/kg it would not take long to cause significant anemia in a 1 kg premature baby. Today, many tests are performed using a drop of blood at the point of care or by using no blood at all, such as with the determination of pulse oximetry or end-tidal CO2. An area that has held the neonatologist’s greatest attention over the past 60 years has been the search for the perfect mechanical ventilator. The fetus in utero receives its oxygenation and eliminates carbon dioxide through the umbilical vessels attached to the placenta. While the fetus’ basic lung structure is complete at 12 weeks of gestation, the arborization of alveoli is not sufficient to sustain life until about 22 weeks. Before that, the distance between the alveolar duct and the pulmonary capillary is too great to achieve sufficient oxygen diffusion. In addition, at this stage the lung is physiologically immature, lacking a key substance called pulmonary surfactant. Surfactant coats the inner walls of the alveolus and inhibits it from totally collapsing between breaths. Surfactant production begins around the 20 th week of gestation, but production is not optimum until near term. Absent of pulmonary surfactant, the lungs are stiff and require significant airway pressure to ventilate. The pressure required, or the tidal volume of air it produces, while needed to affect survival, often damages the premature baby’s small airways and immature alveoli leading to chronic lung disease. We now have artificial surfactants, made of minced calf or porcine lung, that supplement the premature infant’s own surfactant production in the first days of life. This often mitigates the need for artificial ventilation. But the search for the perfect ventilator goes on. The real holy grail in neonatology would be the artificial placenta. For no matter how perfect the ventilator, unless the structure of the lung allows gas exchange, survival is not possible before the alveoli approximate the pulmonary capillaries at around 22 weeks. Extra-corporal membrane oxygenation (ECMO) is possible in babies weighing as little as 2 kg but it is fraught with complications such as intracranial hemorrhage. Japanese and Australian researchers have recently made some progress towards achieving an ex vivo uterine environment therapy for premature lambs. 2 The ability to provide nutrition to the premature infant is also essential in achieving improved survival. Everything about a premature infant is immature, including the gastrointestinal system. Premature infants do not have the neurologic development to coordinate sucking, swallowing and breathing and need tube feedings. The stomach does not produce acid well. The intestines lack digestive enzymes and effective motility. The search for the perfect formula led us back to human breast milk. But even breast milk cannot match the placenta’s ability to provide sufficient nutrients for optimum brain growth and body growth. Since the latter part of the 20 th century, total parenteral nutrition (TPN) has been helpful in improving survival but indeed it is not “total” and brain and body growth still lag behind the optimum intrauterine environment in both quantitative and qualitative measures. In the past 60 years, there have been many more technologic advances addressing the immaturity of all organ systems of the premature infant. This technology is expensive. Today a basic incubator can cost several thousand dollars and the most sophisticated, $20,000. The highest level of care in the modern neonatal intensive care unit can exceed four to five thousand dollars per day, and the three-month hospital stay of a premature infant born at 25 weeks gestation can tally nearly a million dollars. So, with all this technology and investment, how are we doing? There is no doubt that most premature babies born between 28 weeks gestation and term do very well. Many centers now report over 90% survival in those born at 28 weeks, with less than 10% of the survivors having significant long-term health problems. The length of their hospital stays are about eight weeks. Survival increases, and developmental complications decrease, with increasing gestational age. Many babies born between 26 weeks and 28 weeks also do well. Those babies born below 26 weeks however present a major challenge, both practically and ethically, to parents and caregivers. Recently, the National Institute of Child Health and Human Development produced an online outcome calculator for these tiniest of babies: www.nichd.nih.gov/research/supported/EPBO/use. By entering a baby’s birth information, one can see the outcomes of similar babies that were born at 22 to 25 weeks gestation between 2006 and 2012. For example, a baby born as a singleton male at 22 weeks gestation, weighing 401 g (14 oz), whose mother received prenatal steroids, and for whom resuscitation and active management was chosen, would have an average survival of 17% (range 10% to 28%). And, of the survivors, at 18 months of age, 52% – 78% would have moderate-severe neurodevelopmental delay and 15% – 22% moderate-severe cerebral palsy. The field of neonatology has always had it ethical challenges. Does the sanctity of life demand survival at all costs? Who decides? Will society’s support for the pursuit of an infant’s survival at earlier and earlier gestations, so present in the 19 th and 20 th century, apply to the 21 st ? Will there continue to be future scientific and technological advances in the field of neonatology equivalent to those of the 20 th century? These are questions for society and the next generation of neonatologists. References PEDIATRICS 1 Raffel, Dawn. The Strange Case of Dr. Couney: How a Mysterious European Showman Saved Thousands of American Babies. New York, New York, Penguin Random House, 2018. 2 Usuda H, Watanabe S, Miura Y, et al. Successful maintenance of key physiological parameters in preterm lambs treated with ex vivo uterine environment therapy for a period of 1 week. Am J Obst Gynecol. 2017;217:457.e1-57. e13. John L. Roberts is a neonatologist and Professor of Pediatrics at the University of Louisville School of Medicine. AUGUST 2020 11